These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 10933940

  • 1. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J, Gorantla S, Banda N, Cagnon L, Rossi J, Akkina R.
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [Abstract] [Full Text] [Related]

  • 2. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J, Rossi J, Akkina R.
    AIDS Res Hum Retroviruses; 2001 Mar 20; 17(5):385-99. PubMed ID: 11282007
    [Abstract] [Full Text] [Related]

  • 3. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
    Bai J, Banda N, Lee NS, Rossi J, Akkina R.
    Mol Ther; 2002 Dec 20; 6(6):770-82. PubMed ID: 12498773
    [Abstract] [Full Text] [Related]

  • 4. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH, Bühler B, Steinberger P, Tschan MP, Barbas CF, Torbett BE.
    Gene Ther; 2006 Oct 20; 13(20):1480-92. PubMed ID: 16738691
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
    Akkina R, Banerjea A, Bai J, Anderson J, Li MJ, Rossi J.
    Anticancer Res; 2003 Oct 20; 23(3A):1997-2005. PubMed ID: 12894572
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
    Anderson J, Akkina R.
    Gene Ther; 2007 Sep 20; 14(17):1287-97. PubMed ID: 17597795
    [Abstract] [Full Text] [Related]

  • 9. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells.
    Plavec I, Voytovich A, Moss K, Webster D, Hanley MB, Escaich S, Ho KE, Böhnlein E, DiGiusto DL.
    Gene Ther; 1996 Aug 20; 3(8):717-24. PubMed ID: 8854097
    [Abstract] [Full Text] [Related]

  • 10. Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells.
    Seiter K, Kancherla R, Yang L, Quan S, Farley TJ, Abraham NG, Ahmed T.
    J Investig Med; 1999 Sep 20; 47(8):414-24. PubMed ID: 10510594
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies.
    Li X, Gervaix A, Kang D, Law P, Spector SA, Ho AD, Wong-Staal F.
    Gene Ther; 1998 Feb 20; 5(2):233-9. PubMed ID: 9578843
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE, Wong FE, Connole M, Qiu G, Lee L, Gillis J, Lu X, Humeau L, Slepushkin V, Binder GK, Dropulic B, Johnson RP.
    Mol Ther; 2005 Dec 20; 12(6):1157-67. PubMed ID: 16168713
    [Abstract] [Full Text] [Related]

  • 14. Stem cells as vehicles for gene therapy: novel strategy for HIV infection.
    Ho AD, Li X, Lane TA, Yu M, Law P, Wong-Staal F.
    Stem Cells; 1995 Dec 20; 13 Suppl 3():100-5. PubMed ID: 8747996
    [Abstract] [Full Text] [Related]

  • 15. Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS.
    Ngok FK, Mitsuyasu RT, Macpherson JL, Boyd MP, Symonds GP, Amado RG.
    Methods Mol Biol; 2004 Dec 20; 252():581-98. PubMed ID: 15017082
    [Abstract] [Full Text] [Related]

  • 16. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J, Mimuro J, Ogata K, Tabata T, Ueda Y, Ishiwata A, Kimura K, Takano K, Madoiwa S, Mizukami H, Hanazono Y, Kume A, Hasegawa M, Ozawa K, Sakata Y.
    J Gene Med; 2004 Oct 20; 6(10):1049-60. PubMed ID: 15386735
    [Abstract] [Full Text] [Related]

  • 17. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
    Cordelier P, Kulkowsky JW, Ko C, Matskevitch AA, McKee HJ, Rossi JJ, Bouhamdan M, Pomerantz RJ, Kari G, Strayer DS.
    Gene Ther; 2004 Nov 20; 11(22):1627-37. PubMed ID: 15295615
    [Abstract] [Full Text] [Related]

  • 18. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
    Bauer G, Sauter S, Ibanez C, Rice CR, Valdez P, Jolly D, Kohn DB.
    Biol Blood Marrow Transplant; 1998 Nov 20; 4(3):119-27. PubMed ID: 9923409
    [Abstract] [Full Text] [Related]

  • 19. Arrest of in vitro T cell differentiation of normal bone marrow-derived CD34+ stem cells with thymic epithelial fragments from children with AIDS.
    Ruiz ME, Freeman J, Bouhasin JD, Knutsen AP, Hendrix MJ.
    Stem Cells; 1996 Sep 20; 14(5):533-47. PubMed ID: 8888494
    [Abstract] [Full Text] [Related]

  • 20. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
    Strayer DS, Pomerantz RJ, Yu M, Rosenzweig M, BouHamdan M, Yurasov S, Johnson RP, Goldstein H.
    Gene Ther; 2000 May 20; 7(10):886-95. PubMed ID: 10845727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.